In last trading session, Aehr Test Systems (NASDAQ:AEHR) saw 0.3 million shares changing hands with its beta currently measuring 2.19. Company’s recent per share price level of $8.76 trading at $0.07 or 0.81% at ring of the bell on the day assigns it a market valuation of $260.79M. That closing price of AEHR’s stock is at a discount of -144.75% from its 52-week high price of $21.44 and is indicating a premium of 28.42% from its 52-week low price of $6.27. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.47 million shares which gives us an average trading volume of 903.30K if we extend that period to 3-months.

For Aehr Test Systems (AEHR), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.01 in the current quarter.

Aehr Test Systems (NASDAQ:AEHR) trade information

Upright in the green during last session for gaining 0.81%, in the last five days AEHR remained trading in the green while hitting it’s week-highest on Friday, 04/25/25 when the stock touched $8.76 price level, adding 1.46% to its value on the day. Aehr Test Systems’s shares saw a change of -47.32% in year-to-date performance and have moved 8.28% in past 5-day. Aehr Test Systems (NASDAQ:AEHR) showed a performance of -1.46% in past 30-days. Number of shares sold short was 6.52 million shares which calculate 7.64 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 25 to the stock, which implies a rise of 64.96% to its current value. Analysts have been projecting 25 as a low price target for the stock while placing it at a high target of 25. It follows that stock’s current price would drop -185.39% in reaching the projected high whereas dropping to the targeted low would mean a loss of -185.39% for stock’s current value.

Aehr Test Systems (AEHR) estimates and forecasts

This year revenue growth is estimated to fall -9.83% from the last financial year’s standing.

2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 14.83M for the same. And 1 analysts are in estimates of company making revenue of 17M in the next quarter. Company posted 16.6M and 13.12M of sales in current and next quarters respectively a year earlier.

In 2025, company’s earnings growth rate is likely to be around -82.29% while estimates for its earnings growth in next 5 years are of -18.51%.

Aehr Test Systems (NASDAQ:AEHR)’s Major holders

Insiders are in possession of 5.01% of company’s total shares while institution are holding 70.98 percent of that, with stock having share float percentage of 74.73%. Investors also watch the number of corporate investors in a company very closely, which is 70.98% institutions for Aehr Test Systems that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at AEHR for having 2.11 million shares of worth $23.52 million. And as of 2024-06-30, it was holding 7.2724 of the company’s outstanding shares.

The second largest institutional holder is BLACKROCK INC., which was holding about 1.9 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.5749 of outstanding shares, having a total worth of $21.26 million.

On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 860.41 shares of worth $7.54 million or 2.89% of the total outstanding shares. The later fund manager was in possession of 738.19 shares on Mar 31, 2025 , making its stake of worth around $6.47 million in the company or a holder of 2.48% of company’s stock.